封面
市場調查報告書
商品編碼
2087687

獸醫分子診斷市場:2026-2032年全球市場預測(依產品類型、技術、動物種類、疾病及最終使用者分類)

Veterinary Molecular Diagnostic Market by Product, Technology, Animal Type, Disease Type, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,獸醫分子診斷市場規模將達到 23.5 億美元,複合年成長率為 7.90%。

主要市場統計數據
基準年 2025 13.8億美元
預計年份:2026年 14.9億美元
預測年份 2032 23.5億美元
複合年成長率 (%) 7.90%

獸醫分子診斷市場概覽

獸醫分子診斷正成為現代動物醫學的核心領域,因為它能夠以更高的分析靈敏度和更快的速度識別病原體、遺傳標記和抗生素抗藥性決定因素,優於許多培養方法。聚合酵素鏈鎖反應(PCR)、即時定量PCR(qPCR)、逆轉錄PCR、等溫擴增、微陣列和次世代定序(NGS)等技術現已廣泛應用於伴侶動物照護、畜牧生產、馬科動物醫學、野生動物健康管理、水產養殖和肉類用動物生物安全等領域。

獸醫檢測領域的變革性變化

快速PCR平台、多重檢測板、攜帶式核酸檢測和基於定序的流行病學技術的融合正在重塑獸醫分子診斷領域。獸醫院和實驗室正從單一病原體檢測轉向能夠區分臨床表現相似的呼吸道、消化道、生殖系統和媒介傳播疾病的多重檢測,從而能夠更快地做出治療、隔離和生物安全方面的決策。

人工智慧(AI)的累積影響

人工智慧 (AI) 正在累積提升獸醫分子診斷的各個方面,例如檢測方法開發、工作流程最佳化、生物資訊學和臨床決策支援。 AI 驅動的引子和探針設計能夠篩檢病原體基因組中的保守和特異性區域,從而加速標靶選擇,降低交叉反應的風險,並幫助實驗室即使在病原體變異的情況下也能快速反應。

全球市場主要區域趨勢

由於強勁的寵物消費、完善的參考檢查室網路、大學獸醫醫院以及發展成熟且政府支持的動物疾病監測系統,北美仍然是獸醫分子診斷領域最先進的地區之一。美國受益於國家動物健康檢查室網路等基礎設施,而加拿大的監測系統則支持對牲畜、野生動物和寵物的檢測。墨西哥在畜牧業生產和跨境貿易中扮演著至關重要的角色,這推動了對快速診斷的需求,以確保生物安全和市場進入。

關鍵區域洞察:東協、海灣合作理事會、歐盟、金磚國家、七國集團、北約

在東協地區,獸醫分子診斷的需求與家禽、生豬、​​水產養殖以及新興的伴侶動物照護領域密切相關。該地區畜牧業密集,跨國貿易頻繁,因此快速PCR檢測和監測對於禽流感、非洲豬瘟和其他跨境疾病至關重要。此外,東協的檢測實驗室在食品安全、進口管制和出口認證方面也發揮著日益重要的作用。

主要國家獸醫分子診斷的發展趨勢

美國憑藉其在伴侶動物醫療保健方面的大規模醫療費用支出、龐大的標準檢測實驗室規模以及聯邦和州級的動物疫病監測體系,引領這項技術的應用。加拿大則專注於綜合監測和牲畜健康管理,而墨西哥的家禽、牛和豬產業也為快速可靠的檢測提供了支持。巴西作為世界領先的牛肉和家禽出口國,在獸醫分子診斷領域中扮演著至關重要的角色,疾病監測、認證和生物安全是其不可或缺的環節。

為行業領導者提供的實用建議

產業領導者應優先考慮經臨床檢驗、工作流程高效的分子診斷平台,以應對伴侶動物、牲畜、家禽、水產養殖和馬匹醫學中高負擔疾病的診療。針對呼吸道、消化器官系統、生殖系統和媒介傳播疾病的多參數診斷方案,可透過縮短診斷時間並指導治療、隔離和合理使用抗生素等決策,從而發揮顯著價值。

調查方法

本執行摘要採用系統性的二手資料研究途徑編寫,重點在於動物健康、感染疾病、診斷和公共政策領域的檢驗資訊來源。主要資訊來源世界動物衛生組織(OIE)、美國疾病管制與預防中心(CDC)、美國農業部(USDA)、美國食品藥物管理局(FDA)、歐盟委員會、歐洲食品安全局(EFSA)、各國動物衛生機構、同行評審期刊、獸醫協會和診斷技術提供者的公開資訊。

結論

獸醫學中的分子診斷正從一項專門的檢查室服務轉變為動物健康、公共衛生、食品安全和生物安全的重要策略組成部分。 PCR、qPCR、等溫擴增和定序技術能夠更快、更準確地檢測日益廣泛的動物群體中的感染疾病、遺傳風險和抗生素抗藥性標記。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章 獸醫分子診斷市場:依產品分類

  • 耗材和試劑
    • 酵素
    • 成套工具
    • 探針和引子
  • 裝置
    • PCR裝置
    • 序列器
  • 軟體服務

第8章:獸醫分子診斷市場:依技術分類

  • 常規PCR
  • 數位PCR
  • 等溫擴增
  • 微陣列
  • 次世代定序
    • Illumina定序
    • 離子流定序
    • 牛津奈米孔
  • 即時PCR

第9章:獸醫分子診斷市場:依動物類型分類

  • 水產養殖
    • 魚
    • 貝類和甲殼類動物
  • 鳥類
  • 伴侶動物
    • 貓
    • 狗
  • 家畜
    • 牛
    • 家禽
    • 豬
  • 野生動物

第10章:獸醫分子診斷市場:依疾病類型分類

  • 遺傳性疾病
  • 感染疾病
    • 細菌感染疾病
    • 黴菌感染疾病
    • 寄生蟲感染疾病
    • 病毒感染疾病
  • 腫瘤學

第11章 獸醫分子診斷市場:依最終使用者分類

  • 學術機構
  • 診斷中心
  • 參考實驗室
  • 研究機構
  • 獸醫醫院和診所

第12章 獸醫分子診斷市場:依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 獸醫分子診斷市場:依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 獸醫分子診斷市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第16章:公司簡介

  • Agilent Technologies, Inc.
  • Agrolabo SpA
  • Antech Diagnostics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biomedica Medizinprodukte GmbH & Co. KG
  • bioMerieux SA
  • Bioneer Corporation
  • BioNote, Inc.
  • Generi Biotech sro
  • GZ MED Technology Co., Ltd.
  • HealthGene Corporation
  • Heska Corporation
  • IDEXX Laboratories, Inc.
  • INDICAL BIOSCIENCE GmbH
  • Ingenetix GmbH
  • Innovative Diagnostics SAS
  • LGC Limited
  • Merck KGaA
  • MiDOG Animal Diagnostics LLC
  • Neogen Corporation
  • Novacyt SA
  • PathoSense BV
  • QIAGEN NV
  • Randox Laboratories Ltd.
  • Ring Biotechnology Co., Ltd.
  • Seegene Inc.
  • Thermo Fisher Scientific Inc.
  • Veterinary Molecular Diagnostics, Inc.
  • Zoetis Inc.
Product Code: MRR-034B50030397

The Veterinary Molecular Diagnostic Market is projected to grow by USD 2.35 billion at a CAGR of 7.90% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.38 billion
Estimated Year [2026] USD 1.49 billion
Forecast Year [2032] USD 2.35 billion
CAGR (%) 7.90%

Veterinary Molecular Diagnostics Market Overview

Veterinary molecular diagnostics is becoming a core pillar of modern animal health because it can identify pathogens, genetic markers, and antimicrobial resistance determinants with high analytical sensitivity and faster turnaround than many culture-based methods. Polymerase chain reaction (PCR), real-time quantitative PCR (qPCR), reverse transcription PCR, isothermal amplification, microarrays, and next-generation sequencing (NGS) are now used across companion animal care, livestock production, equine medicine, wildlife health, aquaculture, and food-animal biosecurity.

Demand is supported by structural disease pressure. The CDC reports that 6 in 10 known infectious diseases in people can spread from animals, while 3 in 4 new or emerging infectious diseases in people originate in animals. This zoonotic risk profile makes veterinary infectious disease testing, syndromic panels, antimicrobial resistance detection, and genomic surveillance strategically important for veterinarians, producers, public health agencies, and diagnostic laboratories.

The market's center of gravity is shifting from reactive testing toward early detection, herd-level surveillance, precision treatment decisions, and integrated One Health monitoring. As pet ownership, livestock intensification, cross-border animal trade, and antimicrobial stewardship requirements expand, veterinary molecular diagnostic solutions are increasingly evaluated on accuracy, speed, workflow efficiency, sample-to-answer automation, regulatory compliance, and interoperability with laboratory information systems.

Transformative Shifts in the Veterinary Testing Landscape

The veterinary molecular diagnostics landscape is being reshaped by the convergence of rapid PCR platforms, multiplex panels, portable nucleic-acid testing, and sequencing-based epidemiology. Veterinary hospitals and reference laboratories are moving beyond single-pathogen tests to panels that can differentiate clinically similar respiratory, gastrointestinal, reproductive, and vector-borne diseases, enabling faster treatment, isolation, and biosecurity decisions.

Livestock and poultry producers are also adopting molecular testing to reduce economic losses linked to outbreaks, support vaccination strategies, and comply with trade and animal health rules. Diseases such as avian influenza, African swine fever, bovine respiratory disease complex, foot-and-mouth disease, and porcine reproductive and respiratory syndrome have reinforced the value of rapid detection and traceability across farms, transport networks, and processing environments.

A second major shift is decentralization. Point-of-care and near-patient molecular platforms are reducing reliance on distant laboratories for urgent decisions, while cloud-connected instruments improve result reporting and outbreak visibility. At the same time, laboratories continue to invest in automation, extraction-free workflows, high-throughput qPCR, and NGS to manage larger sample volumes and support genomic surveillance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is cumulatively improving veterinary molecular diagnostics across assay development, workflow optimization, bioinformatics, and clinical decision support. AI-enabled primer and probe design can accelerate target selection by screening pathogen genomes for conserved and specific regions, reducing the risk of cross-reactivity and helping laboratories adapt when pathogens mutate.

In sequencing workflows, machine learning supports read classification, variant calling, antimicrobial resistance gene detection, and outbreak clustering. These capabilities are particularly relevant for One Health surveillance because animal, human, and environmental data must be interpreted together to identify transmission pathways and emerging risks.

AI is also changing laboratory operations. Predictive analytics can help forecast testing demand during seasonal respiratory disease, vector-borne disease, or food-animal outbreak cycles. Automated quality-control flags can identify extraction failure, inhibition, contamination patterns, or unusual positivity rates. For veterinarians, AI-assisted interpretation can support evidence-based test selection and antimicrobial stewardship, provided outputs remain transparent, validated, and supervised by qualified professionals.

Key Regional Insights Across Global Markets

North America remains one of the most advanced regions for veterinary molecular diagnostics due to strong companion animal spending, established reference laboratory networks, university veterinary hospitals, and government-supported animal disease surveillance. The United States benefits from infrastructure such as the National Animal Health Laboratory Network, while Canada's surveillance ecosystem supports livestock, wildlife, and companion animal testing. Mexico's role in livestock production and cross-border trade strengthens demand for rapid diagnostics that support biosecurity and market access.

Europe is shaped by stringent animal health, food safety, and antimicrobial stewardship expectations. The European Union's Animal Health Law and coordinated surveillance approach encourage harmonized disease monitoring, while major veterinary markets such as Germany, France, Italy, Spain, and the United Kingdom maintain strong demand for PCR, qPCR, and sequencing services in companion animal and production animal settings. Russia's large livestock base and transcontinental geography create continuing need for scalable animal disease diagnostics.

Asia-Pacific is expanding as pet ownership rises, livestock systems modernize, and governments invest in disease surveillance following repeated regional threats such as avian influenza and African swine fever. China, India, Japan, South Korea, and Australia represent distinct demand centers, ranging from large-scale food-animal testing to high-value companion animal diagnostics and advanced biosecurity programs. Latin America, led by Brazil and Mexico, is supported by export-oriented livestock and poultry industries where molecular testing strengthens certification, traceability, and outbreak response. The Middle East is investing in food security, equine health, falcon health, and camel disease diagnostics, while Africa's long-term opportunity is tied to transboundary animal disease control, laboratory capacity building, and One Health programs for zoonotic disease monitoring.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, demand for veterinary molecular diagnostics is closely tied to poultry, swine, aquaculture, and emerging companion animal care. The region's dense animal production systems and cross-border trade make rapid PCR and surveillance testing important for avian influenza, African swine fever, and other transboundary diseases. ASEAN laboratories are also increasingly relevant to food safety, import controls, and export certification.

The GCC market is shaped by food security strategies, high-value equine and falcon health, camel disease management, and growing companion animal care. Molecular diagnostics can support rapid outbreak response, quarantine decisions, and import screening in countries that depend heavily on animal and food imports. In the European Union, harmonized regulation, antimicrobial resistance monitoring, animal welfare expectations, and veterinary public health programs continue to strengthen demand for validated molecular assays and interoperable laboratory data.

BRICS countries represent a major strategic demand base because they combine large livestock populations, expanding pet care, and government interest in biosecurity. China, India, and Brazil are especially important due to the scale of animal agriculture and the need to protect trade-sensitive supply chains. G7 markets lead in premium companion animal diagnostics, advanced sequencing, laboratory automation, and regulatory quality systems. NATO countries are relevant from a biosecurity perspective because animal disease surveillance can intersect with food supply resilience, military working animal health, and protection against agroterrorism threats.

Key Country Insights in Veterinary Molecular Diagnostics

The United States leads adoption through large companion animal healthcare expenditure, reference laboratory scale, and federal-state animal disease surveillance. Canada emphasizes integrated surveillance and livestock health, while Mexico's poultry, cattle, and swine industries support demand for fast, reliable testing. Brazil is a critical country for veterinary molecular diagnostics because it is a global leader in beef and poultry exports, making disease monitoring, certification, and biosecurity essential.

In Europe, the United Kingdom maintains strong companion animal and equine diagnostic demand, while Germany and France combine advanced veterinary care with major livestock sectors. Italy and Spain are important for companion animals, swine, poultry, and ruminant health. Russia's large agricultural footprint and disease-control needs support continued use of molecular testing for production animals and transboundary disease risks.

China is a central growth market due to its vast swine and poultry industries, expanding pet care sector, and continued emphasis on biosecurity after African swine fever disruptions. India's opportunity is anchored in dairy, poultry, companion animals, and public-sector disease surveillance. Japan and South Korea represent technologically advanced markets with strong quality expectations, aging pet populations, and high diagnostic standards, while Australia's strict biosecurity environment and export-oriented livestock industry make molecular diagnostics essential for early detection, surveillance, and trade confidence.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated, workflow-efficient molecular diagnostic platforms that address high-burden disease categories in companion animals, livestock, poultry, aquaculture, and equine medicine. Multiplex respiratory, gastrointestinal, reproductive, and vector-borne disease panels can deliver strong value when they shorten time to diagnosis and guide treatment, isolation, and antimicrobial stewardship decisions.

Manufacturers and laboratories should invest in automation, contamination control, sample preparation simplification, cold-chain resilience, and connectivity with practice management and laboratory information systems. These capabilities improve throughput, reduce manual error, and support faster reporting during outbreak conditions. Providers should also design solutions that meet regional regulatory expectations and include robust quality-control documentation.

Strategic partnerships with veterinary schools, reference laboratories, public health agencies, producers, and distributors can accelerate adoption. Leaders should also build AI governance into product roadmaps by validating algorithms, documenting performance, protecting data privacy, and ensuring veterinarians remain central to clinical interpretation.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified sources in animal health, infectious disease, diagnostics, and public policy. Core inputs include publicly available information from organizations such as the World Organisation for Animal Health, the CDC, USDA, FDA, European Commission, EFSA, national animal health agencies, peer-reviewed journals, veterinary associations, and publicly available disclosures from diagnostic technology providers.

The analysis triangulates disease burden, regulatory direction, technology adoption, regional animal health infrastructure, and end-user demand across companion animal, livestock, poultry, equine, aquaculture, and wildlife applications. Market interpretation is grounded in observable drivers such as zoonotic disease risk, antimicrobial resistance monitoring, animal trade requirements, laboratory modernization, and the shift toward molecular and genomic surveillance.

All qualitative insights are reviewed for consistency, plausibility, and relevance to veterinary molecular diagnostics. No unsupported market-size, market-share, or forecast claims are used; the emphasis is on evidence-backed trends, technology adoption patterns, and strategic implications for decision-makers.

Conclusion

Veterinary molecular diagnostics is moving from a specialized laboratory service to a strategic component of animal health, public health, food security, and biosecurity. PCR, qPCR, isothermal amplification, and sequencing technologies are enabling faster and more precise detection of infectious diseases, genetic risks, and antimicrobial resistance markers across a widening set of animal populations.

The strongest opportunities will favor providers that combine validated assays, scalable workflows, regional regulatory alignment, and digital connectivity. AI will further improve assay design, surveillance analytics, and laboratory productivity, but adoption will depend on transparent validation, responsible data governance, and supervised clinical use.

As zoonotic disease risk, livestock trade, pet healthcare expectations, and One Health programs intensify, veterinary molecular diagnostics will remain a high-priority investment area for laboratories, veterinary providers, producers, governments, and diagnostic technology innovators.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Veterinary Molecular Diagnostic Market, by Product

  • 7.1. Consumables & Reagents
    • 7.1.1. Enzymes
    • 7.1.2. Kits
    • 7.1.3. Probes & Primers
  • 7.2. Instruments
    • 7.2.1. PCR Instruments
    • 7.2.2. Sequencers
  • 7.3. Software & Services

8. Veterinary Molecular Diagnostic Market, by Technology

  • 8.1. Conventional PCR
  • 8.2. Digital PCR
  • 8.3. Isothermal Amplification
  • 8.4. Microarray
  • 8.5. Next-Generation Sequencing
    • 8.5.1. Illumina Sequencing
    • 8.5.2. Ion Torrent Sequencing
    • 8.5.3. Oxford Nanopore
  • 8.6. Real-Time PCR

9. Veterinary Molecular Diagnostic Market, by Animal Type

  • 9.1. Aquaculture
    • 9.1.1. Fish
    • 9.1.2. Shellfish
  • 9.2. Avian
  • 9.3. Companion Animals
    • 9.3.1. Cats
    • 9.3.2. Dogs
  • 9.4. Livestock
    • 9.4.1. Cattle
    • 9.4.2. Poultry
    • 9.4.3. Swine
  • 9.5. Wildlife

10. Veterinary Molecular Diagnostic Market, by Disease Type

  • 10.1. Genetic Disorders
  • 10.2. Infectious Diseases
    • 10.2.1. Bacterial Infections
    • 10.2.2. Fungal Infections
    • 10.2.3. Parasitic Infections
    • 10.2.4. Viral Infections
  • 10.3. Oncology

11. Veterinary Molecular Diagnostic Market, by End User

  • 11.1. Academic Institutes
  • 11.2. Diagnostic Centers
  • 11.3. Reference Laboratories
  • 11.4. Research Institutes
  • 11.5. Veterinary Hospitals & Clinics

12. Veterinary Molecular Diagnostic Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Veterinary Molecular Diagnostic Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Veterinary Molecular Diagnostic Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies, Inc.
  • 16.2. Agrolabo S.p.A.
  • 16.3. Antech Diagnostics, Inc.
  • 16.4. Bio-Rad Laboratories, Inc.
  • 16.5. Biomedica Medizinprodukte GmbH & Co. KG
  • 16.6. bioMerieux S.A.
  • 16.7. Bioneer Corporation
  • 16.8. BioNote, Inc.
  • 16.9. Generi Biotech s.r.o.
  • 16.10. GZ MED Technology Co., Ltd.
  • 16.11. HealthGene Corporation
  • 16.12. Heska Corporation
  • 16.13. IDEXX Laboratories, Inc.
  • 16.14. INDICAL BIOSCIENCE GmbH
  • 16.15. Ingenetix GmbH
  • 16.16. Innovative Diagnostics SAS
  • 16.17. LGC Limited
  • 16.18. Merck KGaA
  • 16.19. MiDOG Animal Diagnostics LLC
  • 16.20. Neogen Corporation
  • 16.21. Novacyt S.A.
  • 16.22. PathoSense B.V.
  • 16.23. QIAGEN N.V.
  • 16.24. Randox Laboratories Ltd.
  • 16.25. Ring Biotechnology Co., Ltd.
  • 16.26. Seegene Inc.
  • 16.27. Thermo Fisher Scientific Inc.
  • 16.28. Veterinary Molecular Diagnostics, Inc.
  • 16.29. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONSUMABLES & REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PROBES & PRIMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PROBES & PRIMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PROBES & PRIMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SEQUENCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SEQUENCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SEQUENCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONVENTIONAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONVENTIONAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONVENTIONAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIGITAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ISOTHERMAL AMPLIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MICROARRAY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MICROARRAY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MICROARRAY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ILLUMINA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ILLUMINA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ILLUMINA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ION TORRENT SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ION TORRENT SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ION TORRENT SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL OXFORD NANOPORE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL OXFORD NANOPORE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL OXFORD NANOPORE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AQUACULTURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AQUACULTURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AQUACULTURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FISH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FISH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FISH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SHELLFISH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SHELLFISH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SHELLFISH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AVIAN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AVIAN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AVIAN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL COMPANION ANIMALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL COMPANION ANIMALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL COMPANION ANIMALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CATS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL CATS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL CATS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DOGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DOGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DOGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL LIVESTOCK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL LIVESTOCK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL LIVESTOCK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CATTLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL CATTLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL CATTLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL POULTRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL POULTRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL POULTRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SWINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SWINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SWINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL WILDLIFE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL WILDLIFE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL WILDLIFE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GENETIC DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GENETIC DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GENETIC DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INFECTIOUS DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BACTERIAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FUNGAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PARASITIC INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL VIRAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL DIAGNOSTIC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 225. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 226. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 227. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 228. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 229. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 231. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 232. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 233. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 235. GCC VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 264. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 265. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 266. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 268. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 270. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 271. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 272. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 274. G7 VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 276. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 277. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 279. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 280. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 281. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 283. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 284. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 285. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 287. NATO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 302. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 303. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 304. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 305. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 306. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 308. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 310. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 311. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 312. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 314. CANADA VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 315. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 316. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 317. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 318. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 319. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 320. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 321. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 323. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 324. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 325. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 327. MEXICO VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 329. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 330. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY CONSUMABLES & REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 331. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 332. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 333. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY NEXT-GENERATION SEQUENCING, 2018-2032 (USD MILLION)
  • TABLE 334. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 335. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY AQUACULTURE, 2018-2032 (USD MILLION)
  • TABLE 336. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY COMPANION ANIMALS, 2018-2032 (USD MILLION)
  • TABLE 337. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 338. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2032 (USD MILLION)
  • TABLE 340. BRAZIL VETERINARY MOLECULAR DIAGNOSTIC MARKET SIZE, BY END USER, 2018